Tamarack Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Tamarack Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-375,000	Closed	-$5.06M	–	27
2015 Q3	$5.06M	Sell	375,000 -129,668	-26%	-$1.76M	0.6%	26
2015 Q2	$6.99M	Buy	504,668 +52,535	+12%	+$711K	0.8%	29
2015 Q1	$6.37M	Buy	+452,133	New	+$6.15M	0.84%	29
2014 Q2	–	Sell	-167,625	Closed	-$3.36M	–	32
2014 Q1	$3.36M	Sell	167,625 -107,375	-39%	-$2.32M	0.84%	23
2013 Q4	$5.33M	Buy	+275,000	New	+$4.86M	1.26%	22

Other funds holding OXFD

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Tamarack Capital Management's OXFD Position: Q4 2015 in Review

Tamarack Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2015, closing a stake of 375,000 shares — an estimated $5.06M sold.

Tamarack Capital Management first reported a position in OXFD in Q4 2013 and held it in 5 quarters. The position peaked at $6.99M in Q2 2015. 65 funds tracked by Wall St. Rank hold OXFD as of Q4 2015.

Tamarack Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2015 after selling out during the quarter.
Tamarack Capital Management sold 375,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2015, an estimated $5.06M.
Tamarack Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 5 quarters.
Tamarack Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $6.99M in Q2 2015.
65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2015.

Based on Tamarack Capital Management's 13F filing for Q4 2015.